Prolidase is required for early trafficking events during influenza A virus entry

Journal of Virology

Volumn 88, Issue 19, 2014, Pages 11271-11283

  Pohl, Marie O ^a,b   Edinger, Thomas O ^a,b   Stertz, Silke ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Life Science Zurich   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROLINE DIPEPTIDASE; RIBONUCLEOPROTEIN; SMALL INTERFERING RNA; DIPEPTIDASE;

ANIMAL CELL; ARTICLE; CALF (BOVINE); CATALYSIS; CELL MIGRATION; CELL VIABILITY ASSAY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOSOME; ENZYME ACTIVITY; GENE SILENCING; INFLUENZA VIRUS A; NONHUMAN; PROTEIN DEPLETION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS ENTRY; ANIMAL; CELL LINE; DOG; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; MDCK CELL LINE; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; VIRION; VIROLOGY; VIRUS REPLICATION;

ANIMALS; CELL LINE; DIPEPTIDASES; DOGS; ENDOSOMES; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; MADIN DARBY CANINE KIDNEY CELLS; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; VIRION; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84906979425     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00800-14     Document Type: Article

References (58)

1. Palese P, Shaw ML. 2007. Orthomyxoviridae: the viruses and their replication. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Wise HM, Hutchinson EC, Jagger BW, Stuart AD, Kang ZH, Robb N, Schwartzman LM, Kash JC, Fodor E, Firth AE, Gog JR, Taubenberger JK, Digard P. 2012. Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog. 8:e1002998. http://dx.doi.org/10.1371/journal.ppat .1002998.
3. Baum LG, Paulson JC. 1990. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem. Suppl. 40:35-38.
4. Edinger TO, Pohl MO, Stertz S. 2014. Entry of influenza A virus: host factors and antiviral targets. J. Gen. Virol. 95:263-277. http://dx.doi.org /10.1099/vir.0.059477-0.
5. Patterson S, Oxford JS, Dourmashkin RR. 1979. Studies on the mechanism of influenza virus entry into cells. J. Gen. Virol. 43:223-229. http: //dx.doi.org/10.1099/0022-1317-43-1-223.
6. Matlin KS, Reggio H, Helenius A, Simons K. 1981. Infectious entry pathway of influenza virus in a canine kidney cell line. J. Cell Biol. 91:601-613. http://dx.doi.org/10.1083/jcb.91.3.601.
7. Yoshimura A, Kuroda K, Kawasaki K, Yamashina S, Maeda T, Ohnishi S. 1982. Infectious cell entry mechanism of influenza virus. J. Virol. 43: 284-293.
8. de Vries E, Tscherne DM, Wienholts MJ, Cobos-Jimenez V, Scholte F, Garcia-Sastre A, Rottier PJ, de Haan CA. 2011. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog. 7:e1001329. http://dx.doi.org/10.1371 /journal.ppat.1001329.
9. Sieczkarski SB, Whittaker GR. 2002. Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J. Virol. 76:10455-10464. http://dx.doi.org/10.1128/JVI.76.20.10455-10464.2002.
10. Maeda T, Ohnishi S. 1980. Activation of influenza virus by acidic media causes hemolysis and fusion of erythrocytes. FEBS Lett. 122:283-287. http: //dx.doi.org/10.1016/0014-5793(80)80457-1.
11. Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, Wang ML, Wiley DC. 1985. Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40:431-439. http://dx.doi.org/10.1016/0092-8674(85)90157-6.
12. White JM, Wilson IA. 1987. Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J. Cell Biol. 105:2887-2896. http://dx.doi.org/10.1083/jcb .105.6.2887.
13. Wharton SA, Belshe RB, Skehel JJ, Hay AJ. 1994. Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine. J. Gen. Virol. 75(Pt 4):945-948.
14. Zhirnov OP. 1990. Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo-and paramyxoviruses. Virology 176:274-279. http://dx.doi.org/10.1016/0042-6822(90)90253-N.
15. O'Neill R, Jaskunas R, Blobel G, Palese P, Moroianu J. 1995. Nuclear import of influenza virusRNAcan be mediated by viral nucleoprotein and transport factors required for protein import. J. Biol. Chem. 270:22701-22704. http://dx.doi.org/10.1074/jbc.270.39.22701.
16. Davies WL, Grunert RR, Haff RF, McGahen JW, Neumayer EM, Paulshock M, Watts JC, Wood TR, Hermann EC, Hoffmann CE. 1964. Antiviral activity of 1-adamantanamine (amantadine). Science 144:862-863. http://dx.doi.org/10.1126/science.144.3620.862.
17. Skehel JJ, Hay AJ, Armstrong JA. 1978. On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride. J. Gen. Virol. 38:97-110. http://dx.doi.org/10.1099/0022-1317-38-1-97.
18. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. 1985. The molecular basis of the specific anti-influenza action of amantadine.EMBOJ. 4:3021-3024.
19. Kim CU, Lew W, Williams MA, Liu H, Zhang L, Swaminathan S, Bischofberger N, Chen MS, Mendel DB, Tai CY, Laver WG, Stevens RC. 1997. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent antiinfluenza activity. J. Am. Chem. Soc. 119:681-690. http://dx.doi.org/10 .1021/ja963036t.
20. Vonitzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, Phan TV, Smythe ML, White HF, Oliver SW, Colman PM, Varghese JN, Ryan DM, Woods JM, Bethell RC, Hotham VJ, Cameron JM, Penn CR. 1993. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363:418-423. http://dx.doi.org/10.1038/363418a0.
21. Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI. 2005. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366:1175-1181. http://dx.doi.org/10 .1016/S0140-6736(05)67338-2.
22. Ison MG. 2011. Antivirals and resistance: influenza virus. Curr. Opin. Virol. 1:563-573. http://dx.doi.org/10.1016/j.coviro.2011.09.002.
23. Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, Newton MA, Ahlquist P, Kawaoka Y. 2008. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454:890-893. http://dx.doi.org/10.1038/nature07151.
24. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ. 2009. The IFITM proteins mediate cellular resistance to influenzaAH1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254. http://dx.doi.org/10.1016/j.cell.2009.12.017.
25. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, Hill DE, Regev A, Hacohen N. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255-1267. http://dx.doi.org/10 .1016/j.cell.2009.12.018.
26. Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie LA, Hess S, Maurer AP, Muller E, Wolff T, Rudel T, Meyer TF. 2010. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463:818-822. http: //dx.doi.org/10.1038/nature08760.
27. Watanabe T, Watanabe S, Kawaoka Y. 2010. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 7:427-439. http://dx .doi.org/10.1016/j.chom.2010.05.008.
28. Konig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, Garcia-Sastre A, Young JA, Palese P, Shaw ML, Chanda SK. 2010. Human host factors required for influenza virus replication. Nature 463:813-817. http://dx.doi.org/10.1038/nature08699.
29. Su WC, Chen YC, Tseng CH, Hsu PW, Tung KF, Jeng KS, Lai MM. 2013. Pooled RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from the endosome during virus entry. Proc. Natl. Acad. Sci. U. S. A. 110:17516-17521. http://dx.doi.org/10.1073/pnas .1312374110.
30. Ward SE, Kim HS, Komurov K, Mendiratta S, Tsai PL, Schmolke M, Satterly N, Manicassamy B, Forst CV, Roth MG, Garcia-Sastre A, Blazewska KM, McKenna CE, Fontoura BM, White MA. 2012. Host modulators ofH1N1cytopathogenicity. PLoS One 7:e39284. http://dx.doi .org/10.1371/journal.pone.0039284.
31. Stertz S, Shaw ML. 2011. Uncovering the global host cell requirements for influenza virus replication via RNAi screening. Microbes Infect. 13:516-525. http://dx.doi.org/10.1016/j.micinf.2011.01.012.
32. Sakai T, Ohuchi M, Imai M, Mizuno T, Kawasaki K, Kuroda K, Yamashina S. 2006. Dual wavelength imaging allows analysis of membrane fusion of influenza virus inside cells. J. Virol. 80:2013-2018. http: //dx.doi.org/10.1128/JVI.80.4.2013-2018.2006.
33. Pasqual G, Rojek JM, Masin M, Chatton JY, Kunz S. 2011. Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog. 7:e1002232. http://dx.doi.org/10.1371/journal.ppat.1002232.
34. McClure MO, Sommerfelt MA, Marsh M, Weiss RA. 1990. The pH independence of mammalian retrovirus infection. J. Gen. Virol. 71(Pt 4):767-773. http://dx.doi.org/10.1099/0022-1317-71-4-767.
35. Perez L, Carrasco L. 1994. Involvement of the vacuolar H(±)-ATPase in animal virus entry. J. Gen. Virol. 75(Pt 10):2595-2606. http://dx.doi.org /10.1099/0022-1317-75-10-2595.
36. Galloway CJ, Dean GE, Marsh M, Rudnick G, Mellman I. 1983. Acidification of macrophage and fibroblast endocytic vesicles in vitro. Proc. Natl. Acad. Sci. U. S. A. 80:3334-3338. http://dx.doi.org/10.1073/pnas.80 .11.3334.
37. Yang L, Li Y, Ding Y, Choi KS, Kazim AL, Zhang Y. 2013. Prolidase directly binds and activates epidermal growth factor receptor and stimulates downstream signaling. J. Biol. Chem. 288:2365-2375. http://dx.doi .org/10.1074/jbc.M112.429159.
38. Yang L, Li Y, Zhang Y. 2014. Identification of prolidase as a high affinity ligand of the ErbB2 receptor and its regulation of ErbB2 signaling and cell growth. Cell Death Dis. 5:e1211. http://dx.doi.org/10.1038/cddis.2014 .187.
39. Eierhoff T, Hrincius ER, Rescher U, Ludwig S, Ehrhardt C. 2010. The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog. 6:e1001099. http://dx.doi.org /10.1371/journal.ppat.1001099.
40. Zona L, Lupberger J, Sidahmed-Adrar N, Thumann C, Harris HJ, Barnes A, Florentin J, Tawar RG, Xiao F, Turek M, Durand SC, Duong FH, Heim MH, Cosset FL, Hirsch I, Samuel D, Brino L, Zeisel MB, Le Naour F, McKeating JA, Baumert TF. 2013. HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. Cell Host Microbe 13:302-313. http://dx .doi.org/10.1016/j.chom.2013.02.006.
41. Guinea R, Carrasco L. 1995. Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells. J. Virol. 69:2306-2312.
42. Inglis SC, Carroll AR, Lamb RA, Mahy BW. 1976. Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology 74:489-503.
43. Huotari J, Meyer-Schaller N, Hubner M, Stauffer S, Katheder N, Horvath P, Mancini R, Helenius A, Peter M. 2012. Cullin-3 regulates late endosome maturation. Proc. Natl. Acad. Sci. U. S. A. 109:823-828. http: //dx.doi.org/10.1073/pnas.1118744109.
44. Lupi A, Rossi A, Vaghi P, Gallanti A, Cetta G, Forlino A. 2005. N-Benzyloxycarbonyl-L-proline: an in vitro and in vivo inhibitor of prolidase. Biochim. Biophys. Acta 1744:157-163. http://dx.doi.org/10.1016/j .bbamcr.2005.03.008.
45. Surazynski A, Miltyk W, Prokop I, Palka J. 2010. Prolidase-dependent regulation of TGF beta (corrected) and TGF beta receptor expressions in human skin fibroblasts. Eur. J. Pharmacol. 649:115-119. http://dx.doi.org /10.1016/j.ejphar.2010.09.034.
46. Mock WL, Green PC. 1990. Mechanism and inhibition of prolidase. J. Biol. Chem. 265:19606-19610.
47. Lowther WT, Matthews BW. 2002. Metalloaminopeptidases: common functional themes in disparate structural surroundings. Chem. Rev. 102: 4581-4608. http://dx.doi.org/10.1021/cr0101757.
48. Surazynski A, Miltyk W, Palka J, Phang JM. 2008. Prolidase-dependent regulation of collagen biosynthesis. Amino Acids 35:731-738. http://dx .doi.org/10.1007/s00726-008-0051-8.
49. Kitchener RL, Grunden AM. 2012. Prolidase function in proline metabolism and its medical and biotechnological applications. J. Appl. Microbiol. 113:233-247. http://dx.doi.org/10.1111/j.1365-2672.2012.05310.x.
50. Powell GF, Rasco MA, Maniscalco RM. 1974. A prolidase deficiency in man with iminopeptiduria. Metabolism 23:505-513. http://dx.doi.org/10 .1016/0026-0495(74)90078-X.
51. Freij BJ, Levy HL, Dudin G, Mutasim D, Deeb M, Der Kaloustian VM. 1984. Clinical and biochemical characteristics of prolidase deficiency in siblings. Am. J. Med. Genet. 19:561-571. http://dx.doi.org/10.1002/ajmg .1320190319.
52. Isemura M, Hanyu T, Gejyo F, Nakazawa R, Igarashi R, Matsuo S, Ikeda K, Sato Y. 1979. Prolidase deficiency with imidodipeptiduria. A familial case with and without clinical symptoms. Clin. Chim. Acta 93: 401-407.
53. Surazynski A, Donald SP, Cooper SK, Whiteside MA, Salnikow K, Liu Y, Phang JM. 2008. Extracellular matrix and HIF-1 signaling: the role of prolidase. Int. J. Cancer 122:1435-1440. http://dx.doi.org/10.1002/ijc .23263.
54. Palka JA, Phang JM. 1997. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J. Cell. Biochem. 67:166 -175. http://dx.doi.org/10.1002/(SICI)1097-4644 (19971101)67:2<166::AID-JCB2>3.0.CO;2-V.
55. Sato M, Sardana MK, Grasser WA, Garsky VM, Murray JM, Gould RJ. 1990. Echistatin is a potent inhibitor of bone resorption in culture. J. Cell Biol. 111:1713-1723. http://dx.doi.org/10.1083/jcb.111.4.1713.
56. Surazynski A, Sienkiewicz P, Wolczynski S, Palka J. 2005. Differential effects of echistatin and thrombin on collagen production and prolidase activity in human dermal fibroblasts and their possible implication in beta1-integrin-mediated signaling. Pharmacol. Res. 51:217-221. http://dx .doi.org/10.1016/j.phrs.2004.08.004.
57. Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S. 2001. Influenza virus propagation is impaired by inhibition of the Raf/ MEK/ERK signalling cascade. Nat. Cell Biol. 3:301-305. http://dx.doi.org /10.1038/35060098.
58. Ehrhardt C, Wolff T, Pleschka S, Planz O, Beermann W, Bode JG, Schmolke M, Ludwig S. 2007. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J. Virol. 81:3058-3067. http://dx.doi.org/10.1128/JVI.02082-06.